Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in Ahmedabad, India.
| Current Price | ₹81.46 |
|---|---|
| Market Cap | ₹24 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 31.3 |
| Return on Equity | 6.96% |
| 52-Week Range | ₹66.00 – ₹90.85 |
| Beta (1Y) | 0.09 |
Ishita Drugs & Industries Ltd. is trading at ₹81.46, with a market capitalisation of ₹24 Cr.
Ishita Drugs & Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Ishita Drugs & Industries Ltd. has a P/E of 31.3 and a return on equity of 6.96%.